Intuitive Surgical Inc. (NASDAQ: ISRG) announces Dave Rosa as next CEO, effective July 1, 2025. Long-serving CEO Gary Guthart to become executive chair.
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Teleflex (NYSE:TFX) and its peers.
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold.
Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
Despite beating on the top and bottom lines, tariff uncertainty makes the outlook for ISRG stock fluid; investors may want to wait for clarity before jumping in
Intuitive Surgical's price target was cut to $590 on tariff concerns, but analysts remain positive on strong growth, new product cycle, and solid balance sheet.
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence.
